# Boehringer Ingelheim completes $76M expansion of pet vaccine plant in Georgia

Boehringer Ingelheim completed a $76 million investment at its Athens, Georgia site, doubling capacity to produce vaccines for pets.

- Type: Expansion
- Announced: 2019-10-09
- Where: Athens, Georgia, United States
- Value: $76.0M
- Starts operating: 9 Oct 2019
- Status: completed
- Capacity: doubled capacity to produce pet vaccines
- Products: pet vaccines
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Boehringer Ingelheim](https://endata.com/companies/25171.md)

## Sources

- [prnewswire.com](https://www.prnewswire.com/news-releases/boehringer-ingelheim-completes-plant-expansion-after-76-million-georgia-investment-300934965.html), 2019-10-09: "Boehringer Ingelheim, a leading provider of animal health products for pets and livestock, marked the completion of work Wednesday after a $76 million investment in its site in Athens, Ga."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.